CSF3 and cancer: Although many of G-CSF drugs were shown to be relatively safe, the major adverse effect of prophylactic use of these G-CSF-related drugs were bone pain (26, 27), bleomycin-induced pulmonary toxicities (28), and other toxicities (29), which could dramatically prolong/delay cancer chemotherapy, increase the treatment cost, and even jeopardize clinical outcome.